Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy

NCT04241367 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT04241367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04241367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
Lead sponsor
National Cancer Center, Korea
Phase
Observational
Overall status
Completed
Start date
March 28, 2019
Completion date
December 31, 2025
Enrollment
420 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas adenocarcinoma